indicated that CK2-mediated SIRT1 phosphorylation at ser164 inhibits SIRT1 enzymatic activity in inflammatory pathologies like nonalcoholic fatty liver disease (90). The gene discussed is SIRT1; the disease is metabolic dysfunction-associated steatotic liver disease.